Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer

Oncology Reports

Volumn 17, Issue 5, 2007, Pages 1033-1036

  Winnes, Marta ^a   Lissbrant, Erik ^a   Damber, Jan Erik ^a   Stenman, Göran ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ERG; ETV1; Fusion gene; Prognosis; Prostate cancer; TMPRSS2

Indexed keywords

DNA BINDING PROTEIN; ETV1 PROTEIN, HUMAN; ONCOPROTEIN; TMPRSS2 EGR FUSION PROTEIN, HUMAN; TMPRSS2-EGR FUSION PROTEIN, HUMAN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AGED; ARTICLE; GENE FUSION; GENETICS; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; DNA-BINDING PROTEINS; GENE FUSION; HUMANS; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PROGNOSIS; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 34547626674     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.5.1033     Document Type: Article

References (24)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
2. Boyle P and Ferlay J: Cancer incidence and mortality in Europe, 2004. Ann Oncol 16: 481-488, 2005. (Pubitemid 40458328)
3. Grönberg H, Damber L and Damber J-E: Familial prostate cancer in Sweden. A nationwide register cohort study. Cancer 77: 138-143, 1996. (Pubitemid 26002749)
4. Sogani PC and Fair WR: Treatment of advanced prostatic cancer. Urol Clin North Am 14: 353-371, 1987. (Pubitemid 17081954)
5. Tomlins SA, Rhodes DR, Perner S, et al: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310: 644-648, 2005. (Pubitemid 41528150)
6. Tomlins SA, Mehra R, Rhodes DR, et al: TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res 66: 3396-3400, 2006.
7. Seth A and Watson DK: ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 41: 2462-2478, 2005. (Pubitemid 41540623)
8. Vaarala MH, Porvari K, Kyllonen A, Lukkarinen O and Vihko P: The TMPRSS2 gene encoding transmembrane serine protease is overexpressed in a majority of prostate cancer patients: detection of mutated TMPRSS2 form in a case of aggressive disease. Int J Cancer 94: 705-710, 2001. (Pubitemid 33035691)
9. Vaarala MH, Porvari KS, Kellokumpu S, Kyllonen AP and Vihko PT: Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues. J Pathol 193: 134-140, 2001. (Pubitemid 32051123)
10. Kim TS, Heinlein C, Hackman RC and Nelson PS: Phenotypic analysis of mice lacking the Tmprss2-encoded protease. Mol Cell Biol 26: 965-975, 2006. (Pubitemid 43146490)
11. Soller MJ, Isaksson M, Elfving P, Soller W, Lundgren R and Panagopoulos I: Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer. Genes Chromosomes Cancer 45: 717-719, 2006. (Pubitemid 43727158)
12. Åman P: Fusion oncogenes in tumor development. Semin Cancer Biol 15: 236-243, 2005.
13. Roix JJ, McQueen PG, Munson PJ, Parada LA and Misteli T: Spatial proximity of translocation-prone gene loci in human lymphomas. Nat Genet 34: 287-291, 2003. (Pubitemid 36792860)
14. Yoshimoto M, Joshua AM, Chilton-Macneill S, Bayani J, Selvarajah S, Evans AJ, Zielenska M and Squire JA: Threecolor FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement. Neoplasia 8: 465-469, 2006. (Pubitemid 44035330)
15. Kovar H: Context matters: The hen or egg problem in Ewing's sarcoma. Semin Cancer Biol 15: 189-196, 2005.
16. Barbouti A, Höglund M, Johansson B, et al: A novel gene, MSI2, encoding a putative RNA-binding protein is recurrently rearranged at disease progression of chronic myeloid leukemia and forms a fusion gene with HOXA9 as a result of the cryptic t(7;17)(p15;q23). Cancer Res 63: 1202-1206, 2003. (Pubitemid 36348696)
17. Graux C, Cools J, Melotte C, et al: Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 36: 1084-1089, 2004. (Pubitemid 41184470)
18. Paulsson K, Bekassy AN, Olofsson T, Mitelman F, Johansson B and Panagopoulos I: A novel and cytogenetically cryptic t(7;21)(p22;q22) in acute myeloid leukemia results in fusion of RUNX1 with the ubiquitin-specific protease gene USP42. Leukemia 20: 224-229, 2006. (Pubitemid 43148659)
19. Asp J, Persson F, Kost-Alimova M and Stenman G: CHCHD7-PLAG1 and TCEA1-PLAG1 gene fusions resulting from cryptic, intrachromosomal 8q rearrangements in salivary gland pleomorphic adenomas. Genes Chromosomes Cancer 45: 820-828, 2006. (Pubitemid 44182440)
20. Behboudi A, Enlund F, Winnes M, et al: Molecular classification of mucoepidermoid carcinomas-Prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer 45: 470-481, 2006.
21. Lestou VS, O'Connell JX, Robichaud M, et al: Cryptic t(X;18), ins(6;18), and SYT-SSX2 gene fusion in a case of intraneural monophasic synovial sarcoma. Cancer Genet Cytogenet 138: 153-156, 2002. (Pubitemid 36020471)
22. Sjögren H, Meis-Kindblom JM, Örndal C, Bergh P, Ptaszynski K, Åman P, Kindblom LG and Stenman G: Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma-cytogenetic, molecular genetic, and cDNA microarray analyses. Am J Pathol 162: 781-792, 2003. (Pubitemid 36237487)
23. Mitelman F, Johansson B and Mertens F: Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer. Nat Genet 36: 331-334, 2004. (Pubitemid 38437252)
24. Petrovics G, Liu A, Shaheduzzaman S, et al: Frequent over-expression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome. Oncogene 24: 3847-3852, 2005. (Pubitemid 40826884)